To investigate the promoting effect of Ruyi Jinhuang Powder on wound repair in rats with radiation-induced skin injury and its potential mechanisms.

Untargeted detection of the chemical components of Ruyi Jinhuang Powder was performed using UHPLC-QE-MS. Seventy-five male SD rats were randomly divided into normal group, model group, triethanolamine group (TEA), Ruyi Jinhuang Powder low-frequency group (Ruyi Jinhuang Powder-L), and Ruyi Jinhuang Powder high-frequency group (Ruyi Jinhuang Powder-H). Except for the normal group, rats in all other groups received a single dose of 90 Gy irradiation on the left buttock to establish a radiation-induced skin injury model, followed by continuous drug treatment for 8 weeks. Wound healing was assessed by wound photography and ImageJ measurement. Histopathological changes were observed via HE staining, and collagen deposition was evaluated by Sirius Red staining and immunohistochemistry. Skin tissues from the normal group, model group, and Ruyi Jinhuang Powder-H group were collected at 4 weeks post-irradiation for DIA quantitative proteomic analysis, followed by functional enrichment analysis of differentially expressed proteins.

A total of 1, 490 annotable compounds were identified by UHPLC-QE-MS, and 95 candidate components were screened based on the physicochemical properties of the topical formulation, providing a chemical basis for subsequent mechanistic analysis. Ruyi Jinhuang Powder promoted wound closure in radiation-induced skin injury, increased the healing rate (P <0.01), alleviated epidermal structural disruption and dermal inflammatory cell infiltration (P <0.001), and improved insufficient collagen deposition and disordered fiber arrangement (P < 0.001, P < 0.000 1), with more pronounced effects in the high-frequency group. Proteomics quantified a total of 9,075 proteins, among which 3,183 differentially expressed proteins were identified between the model group and the normal group, and 1,614 differentially expressed proteins were identified between the Ruyi Jinhuang Powder-H group and the model group. Further analysis revealed that Ruyi Jinhuang Powder reversed 1, 186 abnormally expressed proteins, mainly involving molecules related to epidermal barrier function, keratinization/differentiation, tight junctions, and extracellular matrix remodeling. GO enrichment analysis showed that after Ruyi Jinhuang Powder intervention, the differentially expressed proteins were mainly enriched in biological processes such as intermediate filament organization, response to xenobiotic stimulus, cholesterol biosynthesis, and keratinization. KEGG enrichment analysis showed that the differentially expressed proteins were significantly enriched in pathways including regulation of actin cytoskeleton, endocytosis, MAPK signaling pathway, PI3K-Akt signaling pathway, protein processing in endoplasmic reticulum, ubiquitin-mediated proteolysis, PPAR signaling pathway, NOD-like receptor signaling pathway, and metabolic pathways.

Ruyi Jinhuang Powder can promote wound repair in radiation-induced skin injury, improve histological damage and collagen-related abnormalities, and its mechanisms may involve the regulation of epidermal barrier function, keratinization/differentiation, tight junctions, extracellular matrix remodeling, and protein homeostasis. These findings provide an experimental basis and theoretical foundation for subsequent validation of key targets and functional studies.

Investigating the Clinical Efficacy of a self-formulated Jianpi Chuji Formula in Alleviating Toxic Side Effects Following Immune Checkpoint Inhibitor (ICI) Therapy in Advanced Non-Small Cell Lung Cancer Patients.

A total of 98 patients with advanced non-small cell lung cancer (NSCLC) who received immunotherapy (ICIs) at Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine in Hebei Province from May 2019 to May 2021 were enrolled as study subjects. They were randomly divided into a control group (n=49) and a treatment group (n = 49). The control group received immune checkpoint inhibitor therapy combined with a platinum-based dual-drug regimen. The treatment group received the same regimen supplemented with self-formulated Jianpi Chuji Formula. Changes in thyroid function indicators, Traditional Chinese Medicine (TCM) syndrome scores, Karnofsky Performance Status (KPS), carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1), adverse reaction incidence, and clinical efficacy were compared between the two groups.

Following treatment, both groups exhibited elevated levels of thyroid-stimulating hormone (TSH) and KPS scores. Symptoms including fatigue, skin keratosis, pain, limb numbness, sallow complexion, pulse, dark tongue, total score, total thyroxine (TT₄), free triiodothyronine (FT₃), free thyroxine (FT₄), CYFRA21-1, and CEA levels decreased in both groups, with greater improvement observed in the treatment group compared to the control group (P < 0. 01). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P >0. 05). Compared to the control group, the treatment group demonstrated higher objective response rates (ORR) and disease control rates (DCR) (P <0. 01). Multivariate analysis showed that age and pathological type had no significant effect on treatment response (P >0. 05) ; After 6 months of follow-up, progression-free survival was better in the treatment group than that in the control group (P <0.05).

Treatment with self-formulated Jianpi Chuji Formula in non-small cell lung cancer patients following ICIs therapy demonstrated significant efficacy. This approach effectively improved patients' quality of life, reduced tumor marker levels, enhanced thyroid function, and decreased the incidence of toxic side effects.

To investigate the clinical efficacy of 3HRZE/6HRE regimen assisted by Bushen Huoxue Formula in the treatment of patients with intermediate and advanced renal tuberculosis, and to analyze the safety of this therapeutic strategy.

The clinical data of 122 patients with advanced renal tuberculosis who were treated in Shaanxi Provincial Tuberculosis Prevention and Treatment Hospital from March 2021 to June 2024 were retrospectively analyzed. According to different treatment regimens, they were divided into control group and observation group. 61 patients in the control group were treated with 3HRZE/6HRE regimen alone. 61 patients in the observation group were treated with Bushen Huoxue Formula combined with 3HRZE/6HRE regimen. The course of treatment was 9 months. The clinical efficacy, inflammatory response [interferon-gamma (IFN-γ), interleukin-6 (IL-6), blood sedimentation rate (ESR)], liver and kidney function [azelaic transaminase (AST), blood urea nitrogen (BUN), quantitative 24 h urinary protein (24 h UTP)], quality of life determination scale (QLICD-PT) scores, and the incidence rate of adverse reactions were observed in the two groups.

The total effective rate of the observation group was higher than that of the control group (P <0.05). After treatment, the levels of IFN-γ, IL-6, ESR, BUN, and 24 h UTP were lower than those before treatment in both groups (P <0.05), and the observation group was lower than the control group (P <0.05); and the levels of AST and the scores of each dimension of QLICD-PT were higher than those before treatment, and the observation group was higher than the control group (P <0.05). There was no statistically significant difference in the incidence of adverse reactions in the observation group compared with the control group (P > 0.05).

Bushen Huoxue Formula assisted 3HRZE/6HRE regimen in treating patients with intermediate and advanced renal tuberculosis can significantly improve the therapeutic efficacy and quality of survival, and improve the liver and kidney function, inhibit the expression of inflammation, and have a good safety.

To investigate the application of acupuncture combined with sports acupuncture in the treatment of chronic ankle synovitis based on the theory of " Treating Lower Diseases by Acting on the Upper Body".

98 patients with chronic ankle synovitis admitted to the Department of Soft Tissue Injury of Sichuan Orthopedic Hospital from September 2024 to April 2025 were selected and divided into two groups using the random number method, each with 49 cases. The control group was given conventional treatment, and the treatment group was treated with the 'lower disease upper treatment' theory of acupuncture combined with sports acupuncture for two consecutive weeks. Clinical efficacy, Visual Analog Scale (VAS) scores, degree of ankle swelling, most painful point, pain threshold, ankle joint range of motion, American Orthopaedic Foot and Ankle Society (AOFAS) scores were compared between the two groups.

Treatment group had a higher clinical efficacy rate in contrast to control group (P < 0.05). After treatment, the VAS score, degree of ankle joint swelling and pain threshold in both groups decreased compared with those before treatment, while the AOFAS score and range of motion of the ankle joint increased compared with those before treatment (P < 0.05). Compared with the control group, the treatment group exhibited lower VAS scores, reduced ankle swelling, and lower pain thresholds, while demonstrating higher AOFAS scores, greater ankle range of motion, and a higher number of patients with improvement in the most painful point (P <0.05).

Under the guidance of the " treating the lower disease from the upper" theory, acupuncture combined with sports acupuncture therapy can effectively relieve the pain and swelling symptoms of patients with chronic ankle synovitis, promote the recovery of joint function, and significantly improve the therapeutic effect.

To explore the efficacy of Qutan Huayu Tongbi Decoction combined with VRD regimen in the treatment of multiple myeloma (MM) with phlegm-stasis obstructing collateral syndrome.

A prospective randomized controlled placebo study was conducted, enrolling 132 MM patients with phlegm-stasis obstructing collateral syndrome admitted to the Department of Hematopathy of Qingyang Traditional Chinese Medicine Hospital from January 2022 to December 2024. Patients were randomly divided into two groups using a random number table. The control group (66 cases) received VRD chemotherapy combined with Chinese medicine placebo, while the observation group (66 cases) received VRD chemotherapy combined with Qutan Huayu Tongbi Decoction. Both groups were treated continuously for 4 cycles. The chemotherapy efficacy, TCM syndrome score, degree of bone pain, quality of life, blood biochemistry, coagulation indicators and adverse reactions were compared between the two groups.

The DCR (95. 45% vs 63. 63%), ORR (81. 82% vs 51. 52%), and the total effective rate of traditional Chinese medicine (93. 94% vs 77. 27%) in the observation group were all higher than those in the control group (P <0.01), while the overall incidence of adverse reactions was lower (7. 58% vs 22. 73% , P <0.05). After treatment, both groups showed a decrease in TCM syndrome score, bone pain Visual Analog Scale (VAS) score, and levels of vascular endothelial growth factor (VEGF), derived neutrophil-to-lymphocyte ratio (dNLR), neutrophil-to-lymphocyte ratio (NLR), bone marrow plasma cell proportion, β2-microglobulin (β2-MG), lactate dehydrogenase (LDH), serum creatinine (Scr), blood urea nitrogen (BUN), D-dimer (D-D), and plasma fibrinogen (FIB) compared to before treatment (P < 0.01), with the observation group showing lower values than the control group (P < 0.01). The lymphocyte-to-monocyte ratio (LMR), hemoglobin (Hb), Karnofsky Performance Status (KPS) score, and Activities of Daily Living (ADL) score increased compared to before treatment (P < 0.05), with the observation group showing higher values than the control group (P <0.01). Prothrombin time (PT) and activated partial thromboplastin time (APTT) were prolonged compared to before treatment (P < 0.01), with the observation group showing longer times than the control group (P < 0.01).

The combination of Qutan Huayu Tongbi Decoction and VRD chemotherapy regimen can effectively enhance the therapeutic effect of chemotherapy for multiple myeloma, alleviate clinical symptoms, bone pain and anemia, improve coagulation and renal functions, regulate immune inflammation, enhance the physical condition and quality of life of patients, and has good safety.

To observe the clinical efficacy and safety of self-designed Yiqi Yangyin Tongluo Formula combined with intestinal microecological regulators in the treatment of rheumatoid arthritis.

A prospective cohort study was conducted on 120 patients with rheumatoid arthritis admitted to Xinyang Central Hospital from January 2022 to January 2025, using a random number table method. Both groups received leflunomide tablets. The conventional group was treated with intestinal microecological modulators, while the combined group received self-designed Yiqi Yangyin Tongluo Formula combined with intestinal microecological modulators. Microbiome diversity metrics (evenness and richness), anti-cyclic citrullinated peptide (CCP) antibody levels, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels were measured in both groups. Clinical efficacy outcomes were statistically analyzed.

There was no difference in the uniformity and richness of the microbiome flora between the two groups before treatment (P >0.05). Before and after treatment, the uniformity and richness of the microbiome in both groups increased, and the uniformity and richness of the microbiome in the comprehensive group after treatment were higher than those in the conventional group (P <0.05). There was no difference in the relevant scores between the two groups before treatment (P >0.05). Before and after treatment, the scores of the Arthritis Quality of Life Scale 2 (AIMS2-SF) in both groups increased, and the comprehensive group was higher than the conventional group after treatment (P < 0.05). The TCM symptom scores, DAS28 scores and VAS scores of both groups decreased, and the comprehensive group was lower than the conventional group (P < 0.05). There was no difference in anti-CCP antibody, ESR and CRP between the two groups before treatment (P > 0.05). Before and after treatment, the anti-CCP antibody, ESR and CRP in both groups decreased, and the comprehensive group was lower than the conventional group after treatment (P <0.05). The improvement rate of ACR20 in the comprehensive group was 61. 67%, which was higher than 43. 33% in the conventional group. The improvement rates of ACR50 and ACR70 were 46. 67% and 15. 00% respectively, and there was no difference compared with 31. 67% and 6. 67% in the control group (P >0.05).

The Self-designed Yiqi Yangyin Tongluo Formula combined with intestinal microecological regulators in the treatment of rheumatoid arthritis can reduce the levels of anti-CCP antibody, ESR and CRP, alleviate symptoms.

A total of 82 elderly patients with hypertension complicated by heart failure and deficiency of qi-blood, as well as restlessness of the mind were selected from Henan Provincial Veterans' Hospital from January 2022 to January 2024. They were divided into the control group and the treatment group according to the random number table method, with 41 cases in each group. Both groups were given symptomatic treatment. The control group was treated with valsartan, while the treatment group was treated with Yangxin Decoction combined with valsartan. Both groups were given continuous treatment for 8 weeks. The cardiac function indicators, blood pressure, TLR4/Macrophage Differentiation Factor 88 (MyD88)/Nuclear Factor-κB (NF-κB) pathway factors, C1q Tumor Necrosis Factor-related Protein 3 (CTRP3), N-terminal Brain Natriuretic Peptide precursor (NT-proBNP), Troponin I (cTnI), and high-sensitivity C-reactive protein (hs-CRP) levels were compared between the two groups, and the incidence of adverse reactions was statistically analyzed.

There was no significant difference in the pre-treatment cardiac function indicators, blood pressure, CTRP3, BNP, cTnI, and hs-CRP between the two groups (P >0.05). After treatment, the left ventricular ejection fraction (LVEF), CTRP3, and the ratio of early to late diastolic filling velocity (E/A) in both groups increased compared with those before treatment, while blood pressure, BNP, left ventricular end-systolic diameter (LVESD), cTnI, hs-CRP, and left ventricular end-diastolic diameter (LVEDD) decreased (P <0.05). The LVEF and E/A in the treatment group were higher than those in the control group after treatment, while LVESD and LVEDD were lower (P < 0.05). There was no significant difference in the TLR4/MyD88/NF-κB pathway factors before treatment between the two groups (P > 0.05). After treatment, the relative expression levels of TLR4, MyD88, and NF-κB in both groups decreased compared with those before treatment (P < 0. 05). The relative expression levels of TLR4, MyD88, and NF-κB in the treatment group were lower than those in the control group after treatment (P <0.05). There was no significant difference in the cumulative incidence of adverse reactions between the two groups (P > 0.05).

The combination of Yangxin Decoction and Valsartan can regulate the TLR4/MyD88/NF-κB signaling pathway in elderly patients with hypertension, improve cardiac function, lower blood pressure, and does not increase adverse reactions.

To study the effects of Modified Yulin Zhu combined with warm acupuncture on endometrial receptivity and serum leukemia inhibitory factor (LIF) vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) levels in patients with thin endometrium of renal deficiency and blood stasis type.

84 patients with thin endometrium (renal deficiency and blood stasis type) admitted to Taizhou Hospital of Traditional Chinese Medicine from January 2023 to September 2024 were selected, the grouping method was random number table method, the patients were divided into control group (treated with estradiol tablets/estradiol dydrogesterone tablets composite packaging, 42 cases) and observation group (treated with Modified Yulin Zhu and warm acupuncture on the basis of control group, 42 cases), the clinical efficacy, traditional Chinese medicine syndrome score, menstrual blood volume score, endometrial receptivity, serum LIF, VEGF, MMP-9 and incidence of adverse reactions were compared between two groups.

The total clinical effective rate of the observation group was higher than that of control group (P <0.05). Traditional Chinese medicine syndrome score in observation group were lower than those in control group 3 months after treatment, the endometrial thickness was greater than that in control group, and menstrual blood volume score, serum LIF, MMP-9 and VEGF were higher than those in control group (P <0.01). There was no difference in the incidence of adverse reactions between the observation group and the control group (P > 0.05).

Modified Yulin Zhu combine with warm acupuncture treatment, which can improve the clinical symptoms of patients with thin endometrium of renal deficiency and blood stasis type, and regulate endometrial receptivity, which may be relate to the improvement of serum LIF, VEGF and MMP-9 levels.